Effects of forced disruption in Medicaid managed care on children with asthma

Katherine Piwnica-Worms1,2, Becky Staiger3, Joseph S Ross4,5,6,7

  • 1Department of Pediatrics, NYU Langone School of Medicine, New York, New York, USA.

Health Services Research
|February 24, 2021
PubMed

Insights

Forced changes in Medicaid managed care plans reduced outpatient visits for children with persistent asthma. However, these disruptions did not negatively impact asthma care quality or emergency healthcare use.

Area of Science:

  • Health Services Research
  • Pediatric Asthma Management
  • Managed Care Policy

Background:

  • Medicaid managed care plans are crucial for children's health access.
  • Disruptions to these plans can affect healthcare utilization and outcomes.
  • Understanding the impact on children with persistent asthma is vital for policy evaluation.

Purpose of the Study:

  • To assess how forced changes in Medicaid managed care plans and provider networks influence health utilization and outcomes for children with persistent asthma.
  • To analyze the effects of patient redistribution among managed care plans on healthcare access and quality for this vulnerable population.

Main Methods:

  • Utilized administrative claims data from a southeastern state (2013-2016).
  • Employed a difference-in-difference analysis comparing pre- and post-redistribution periods.
  • Linked enrollment data for children with persistent asthma to administrative claims for continuous enrollment analysis.

Main Results:

  • 26% of children with persistent asthma were forced to switch managed care plans, with 67% also changing primary care providers.
  • Disruption was linked to a 2.1 percentage-point decrease in quarterly outpatient visits.
  • While asthma-specific visits decreased overall, the reduction was less pronounced for children who also switched primary care providers.

Conclusions:

  • Forced disruption of Medicaid managed care plans led to fewer outpatient visits for children with persistent asthma.
  • No significant negative associations were found with asthma care quality indicators or emergency healthcare utilization.
  • Policy changes affecting managed care enrollment require careful consideration of potential impacts on healthcare access for pediatric populations.
Abstract

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
960
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
535